ZNF385A anticorps (C-Term)

N° du produit ABIN1109583

Cet anticorps anti-ZNF385A est un anticorps Lapin Polyclonal détectant ZNF385A dans WB et IHC (p). Adapté pour Humain, Souris, Rat, Boeuf (Vache) et Poisson zèbre (Danio rerio).

Aperçu rapide pour ZNF385A anticorps (C-Term) (ABIN1109583)

Antigène: ZNF385A (Zinc Finger Protein 385A (ZNF385A))

Reactivité: Humain, Souris, Rat, Boeuf (Vache), Poisson zèbre (Danio rerio)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ZNF385A est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-ZNF385A anticorps

Épitope: C-Term

Séquence: LKQHISSRRH RDGVAGKPNP LLSRHKKSRG AGELAGTLTF SKELPKSLAG

Réactivité croisée (Details): Species reactivity (expected):Mouse, Rat, Zebrafish, BovineSpecies reactivity (tested):Human

Purification: Purified on peptide immunoaffinity column

Immunogène: The immunogen for anti-ZNF385 antibody: synthetic peptide directed towards the C terminal of human ZNF385.

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Reconstitution: Add 50 μL of distilled water

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: -20 °C

Stockage commentaire: Store the lyophised antibody at -20 °C for up to one year. Store reconstitued antibody undiluted for one month or in aliquots at -20 °C long term.

Date de péremption: 12 months

Détails sur ZNF385A

Antigène: ZNF385A (Zinc Finger Protein 385A (ZNF385A))

Autre désignation: ZNF385A

Sujet: Results suggest that RZF is a shuttling regulatory protein expressed in photoreceptors of the human retina that may be involved in mRNA or protein regulation of photoreceptor-specific genes and therefore have role in retinal disease mechanisms.Synonyms: HZF, Hematopoietic zinc finger protein, RZF, Retinal zinc finger protein, ZNF385, Zinc finger protein 385A

ID gène: 25946

NCBI Accession: NP_056296

Pathways: Positive Regulation of Response to DNA Damage Stimulus, Negative Regulation of intrinsic apoptotic Signaling, Positive Regulation of fat Cell Differentiation